超声作为腹主动脉瘤腔内修复术后唯一随访方式的安全性
该回顾性研究纳入2013至2021年213例EVAR患者,比较初始超声随访(91例)与初始CT随访(37例)的结果。两组在动脉瘤增长、内漏及再次干预方面无显著差异,随访期间无动脉瘤破裂。作者认为,在选择性低风险患者中,超声是可行的唯一随访方式。
要点
- EVAR术后初始超声随访与初始CT随访的患者年龄、BMI及动脉瘤直径无显著差异。
- 超声随访组15例发现内漏和/或瘤体增长,其中3例最终需EVAR翻修。
- 低风险亚组(术前直径≤5.5 cm、BMI≤30、术中无内漏)中,无论超声或CT随访均无患者需再次干预。
核心结论
- 作者认为,尽管EVAR术后初始CT随访仍理想,但在选择性低风险患者中,超声是可行的替代方案,甚至可用于术后首次检查。
- 作者数据提示,在选择性患者中,超声是EVAR术后安全唯一的随访方式。
研究设计与样本
- 回顾性研究,纳入本机构血管数据库2013至2021年213例EVAR患者,排除开窗EVAR和烟囱重建。
- 分析患者人口学/结局、腹主动脉瘤特征及随访方式和结果,采用非配对Student t检验、方差分析和卡方检验比较组间差异。
主要发现
- 213例EVAR患者中85例(39.9%)在3个月内失访;剩余128例中,91例初始采用超声随访,37例初始采用CT随访。
- 超声随访组与CT随访组患者年龄分别为75.5±9.4岁与75.3±8.5岁,BMI分别为27.7±5.4与28.9±7.4,平均腹主动脉瘤直径分别为5.6±1.1 cm与5.9±1.2 cm,差异均无统计学意义(P>0.05)。
- 91例初始超声随访患者中,15例发现内漏和/或腹主动脉瘤增长(>5 mm),这15例均行确认性CT血管造影,其中3例最终需EVAR翻修。
- 37例初始CT随访患者中,10例发现显著增长,其中2例最终需EVAR翻修。
- 随访期间无患者发生腹主动脉瘤破裂;超声组平均随访29.5±26.4个月,CT组平均随访26.4±22.3个月(P>0.05)。
临床怎么用
- 作者认为,EVAR术后初始CT随访仍理想。
- 作者认为,在选择性低风险患者中,超声是可行的替代方案,甚至可用于术后首次检查,优点包括减少辐射暴露和降低成本。
- 作者数据提示,在选择性患者中,超声是EVAR术后安全唯一的随访方式。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Post endovascular aneurysm repair (EVAR), surveillance with computed tomography-aortography (CTA) remains the most common practice, per Society for Vascular Surgery (SVS) guidelines. Chronic exposure to both radiation and intravenous (IV) contrast has raised concerns about long-term CTA follow-up (FU). As we have selectively used ultrasound (US) as a sole modality for post-EVAR surveillance, we sought to review our outcomes in this subset of patients. METHODS: Retrospective review of our institution's vascular database identified 213 EVAR patients from 2013 to 2021. Fenestrated-EVAR and snorkel reconstructions were excluded. Patient demographics/outcomes, abdominal aortic aneurysm (AAA) characteristics, and FU modalities and outcomes were analyzed. Unpaired Student's t-test, ANOVA, and chi-squared test were used to assess group differences. RESULTS: Eighty-five of the 213 EVAR patients (39.9%) were lost to FU within 3 months. Among the 128 remaining patients, 91 underwent FU using initial US, while 37 patients underwent post-EVAR FU initially using CTA. There were no significant differences (P > 0.05) between patient age (75.5 ± 9.4 vs. 75.3 ± 8.5), body mass index (BMI) (27.7 ± 5.4 vs. 28.9 ± 7.4), or mean AAA size (5.6 ± 1.1 vs. 5.9 ± 1.2) in US-surveilled and computed tomography (CT)-surveilled groups, respectively. Of the 91 patients, initially surveilled with US, 15 patients demonstrated endoleak and/or AAA growth (>5 mm). The 15 patients with US-demonstrated endoleak and/or growth underwent confirmatory CTA, with 3 patients eventually requiring EVAR revision. Among 37 patients initially surveilled with CT, 10 demonstrated significant growth and 2 patients eventually required EVAR revision. There were no patients with AAA rupture during post-EVAR surveillance. FU data were analyzed among a select lower-risk group of patients (preoperative AAA diameter ≤5.5 cm, BMI ≤30, and no endoleak at completion of EVAR). Among this group, there were no surveilled patients who required EVAR reintervention, regardless of surveillance modality (US n = 32; CT n = 4). The average FU was 29.5 ± 26.4 months in the US group and 26.4 ± 22.3 months in the CT group (P > 0.05). CONCLUSIONS: Although initial CT surveillance following EVAR remains ideal, in select lower-risk patients, US is a viable alternative even for the initial post-procedure study. Advantages include decreased radiation exposure and cost. Our data suggest that US is a safe sole modality for surveillance following EVAR in selective patients.
引用
- Shukla K, Messner M, Albuquerque F, et al. Safety of Utilizing Ultrasound as the Sole Modality of Follow-Up after Endovascular Aneurysm Repair. Ann Vasc Surg. 2022. PMID: 36572095. doi:10.1016/j.avsg.2022.12.068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。